Maria Carolina Andrade Serafim

Ms. Maria Carolina Andrade Serafim

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in Economies
Verified
Journal Article
Open access
PDF file
Patricia Véras MarronePatricia Véras Marrone
Patricia Véras Marrone
FMFabio Rampazzo Mathias
Fabio Rampazzo Mathias
WBWanderley Bernardo
Wanderley Bernardo
MOMarina Orlandini
Marina Orlandini
MSMaria Carolina Andrade Serafim
Maria Carolina Andrade Serafim
EDEduardo Mario Dias
Eduardo Mario Dias
(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when confronted by a major global health and humanitarian crisis, many countries have taken steps to mitigate the risks of disruption, including, for example, recommending the adoption of a plus one diversification approach, increasing safety stock, and nationalizing the medical supply chains. (2) Objective: To scope findings in the academic literature related to decision criteria to guide national policy decisions for the “Partial Nationalization of Pharmaceutical Supply Chain” (PNPSC) from the viewpoints of the three main stakeholders: industry, payers (government and health insurance), and patients. (3) Methods: These consist of a scoping review of the peer-reviewed literature. (4) Results: A total of 115 studies were included. For local manufacturing decisions, five criteria and 15 sub-criteria were identified. Weighting, decision-making, risk assessment, and forecasting were the main data analysis tools applied; (5) Conclusions: The findings could serve as a baseline for constructing PNPSC frameworks after careful adaptation to the local context.